NYSE:TMOLife Sciences
What Thermo Fisher Scientific (TMO)'s FDA Clearance for EXENT System Means for Shareholders
Thermo Fisher Scientific has received FDA 510(k) clearance for its EXENT System, an automated platform designed to enhance the diagnosis of multiple myeloma and related blood disorders by improving result accuracy and clinical workflow efficiency for laboratories in the U.S. and several international markets.
This regulatory milestone expands Thermo Fisher’s commercial reach in the diagnostics sector, reflecting how innovation in laboratory automation can influence patient care and clinical...